Cargando…
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
INTRODUCTION: Malignant pleural mesothelioma (MPM) is an incurable malignant disease, which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast activation protein (FAP) is predominantly expressed on the surface of reactive tumor-associated fibroblasts as well as on p...
Autores principales: | Schuberth, Petra C, Hagedorn, Christian, Jensen, Shawn M, Gulati, Pratiksha, van den Broek, Maries, Mischo, Axel, Soltermann, Alex, Jüngel, Astrid, Marroquin Belaunzaran, Osiris, Stahel, Rolf, Renner, Christoph, Petrausch, Ulf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751305/ https://www.ncbi.nlm.nih.gov/pubmed/23937772 http://dx.doi.org/10.1186/1479-5876-11-187 |
Ejemplares similares
-
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
por: Schuberth, Petra C, et al.
Publicado: (2013) -
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
por: Petrausch, Ulf, et al.
Publicado: (2012) -
FAP-specific re-directed T cells first in-man study in malignant pleural mesothelioma: experience of the first patient treated
por: Pircher, Magdalena, et al.
Publicado: (2015) -
CD28 co-stimulation induced Lck signaling is important for survival and antigen-specific functionality of re-directed T cells
por: Gulati, Pratiksha, et al.
Publicado: (2013) -
HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats
por: Marroquin Belaunzaran, Osiris, et al.
Publicado: (2015)